Alembic gets USFDA nod for generic pain-relief medication

The company's product is therapeutically equivalent to Roche Palo Alto LLC's Toradol Injection. Ketorolac Tromethamine is indicated for the short-term management of moderately severe acute pain in adult patients.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dEyCtQa
via IFTTT